Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C43H52N4O5 |
| Molecular Weight | 704.8968 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 9 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12[C@@H](CC)C[C@H]3C[N@@]1CCC4=C(NC5=C4C=C(OC)C(=C5)C6C[C@@H]7[C@@H]([C@H](CC8=C6NC9=C8C=CC=C9)N(C)CC7=CC)C(=O)OC)[C@@]2(C3)C(=O)OC
InChI
InChIKey=VCMIRXRRQJNZJT-KXIWAJSYSA-N
InChI=1S/C43H52N4O5/c1-7-24-15-23-20-43(42(49)52-6)39-27(13-14-47(21-23)40(24)43)29-19-36(50-4)30(17-34(29)45-39)31-16-28-25(8-2)22-46(3)35(37(28)41(48)51-5)18-32-26-11-9-10-12-33(26)44-38(31)32/h8-12,17,19,23-24,28,31,35,37,40,44-45H,7,13-16,18,20-22H2,1-6H3/b25-8-/t23-,24+,28+,31?,35+,37?,40+,43-/m1/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Voacamine, a bisindolic alkaloid from Peschiera fuchsiaefolia, enhances the cytotoxic effect of doxorubicin on multidrug-resistant tumor cells. | 2003 Dec |
|
| Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells. | 2005 Dec |
|
| Autophagy-mediated chemosensitizing effect of the plant alkaloid voacamine on multidrug resistant cells. | 2007 Mar |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
82591
Created by
admin on Sat Dec 16 10:59:26 GMT 2023 , Edited by admin on Sat Dec 16 10:59:26 GMT 2023
|
PRIMARY | |||
|
146230
Created by
admin on Sat Dec 16 10:59:26 GMT 2023 , Edited by admin on Sat Dec 16 10:59:26 GMT 2023
|
PRIMARY | |||
|
5100
Created by
admin on Sat Dec 16 10:59:26 GMT 2023 , Edited by admin on Sat Dec 16 10:59:26 GMT 2023
|
PRIMARY | |||
|
141966
Created by
admin on Sat Dec 16 10:59:26 GMT 2023 , Edited by admin on Sat Dec 16 10:59:26 GMT 2023
|
PRIMARY | |||
|
3371-85-5
Created by
admin on Sat Dec 16 10:59:26 GMT 2023 , Edited by admin on Sat Dec 16 10:59:26 GMT 2023
|
PRIMARY | |||
|
DB04877
Created by
admin on Sat Dec 16 10:59:26 GMT 2023 , Edited by admin on Sat Dec 16 10:59:26 GMT 2023
|
PRIMARY | |||
|
m11493
Created by
admin on Sat Dec 16 10:59:26 GMT 2023 , Edited by admin on Sat Dec 16 10:59:26 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID20863159
Created by
admin on Sat Dec 16 10:59:26 GMT 2023 , Edited by admin on Sat Dec 16 10:59:26 GMT 2023
|
PRIMARY | |||
|
222-151-3
Created by
admin on Sat Dec 16 10:59:26 GMT 2023 , Edited by admin on Sat Dec 16 10:59:26 GMT 2023
|
PRIMARY | |||
|
m11493
Created by
admin on Sat Dec 16 10:59:26 GMT 2023 , Edited by admin on Sat Dec 16 10:59:26 GMT 2023
|
PRIMARY | Merck Index | ||
|
Voacamine
Created by
admin on Sat Dec 16 10:59:26 GMT 2023 , Edited by admin on Sat Dec 16 10:59:26 GMT 2023
|
PRIMARY | |||
|
2Z504YT5AG
Created by
admin on Sat Dec 16 10:59:26 GMT 2023 , Edited by admin on Sat Dec 16 10:59:26 GMT 2023
|
PRIMARY | |||
|
90479276
Created by
admin on Sat Dec 16 10:59:26 GMT 2023 , Edited by admin on Sat Dec 16 10:59:26 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
